Viewing Study NCT02824094


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-02 @ 4:24 PM
Study NCT ID: NCT02824094
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2017-07-21
First Post: 2016-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module